Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2012, Article ID 735486, 10 pages
http://dx.doi.org/10.1155/2012/735486
Review Article

Brain Abnormalities in Neuromyelitis Optica Spectrum Disorder

1Department of Neurology, The Catholic University of Korea, Seoul, Republic of Korea
2Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang 410-769, Republic of Korea

Received 27 August 2012; Accepted 2 November 2012

Academic Editor: Friedemann Paul

Copyright © 2012 Woojun Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Kim, S. H. Kim, and H. J. Kim, “New insights into neuromyelitis optica,” Journal of Clinical Neurology, vol. 7, no. 3, pp. 115–127, 2011. View at Google Scholar
  2. P. V. A. Lennon, D. M. Wingerchuk, T. J. Kryzer et al., “A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis,” The Lancet, vol. 364, no. 9451, pp. 2106–2112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. V. A. Lennon, T. J. Kryzer, S. J. Pittock, A. S. Verkman, and S. R. Hinson, “IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel,” Journal of Experimental Medicine, vol. 202, no. 4, pp. 473–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. J. Pittock, B. G. Weinshenker, C. F. Lucchinetti, D. M. Wingerchuk, J. R. Corboy, and V. A. Lennon, “Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression,” Archives of Neurology, vol. 63, no. 7, pp. 964–968, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Nielsen, E. A. Nagelhus, M. Amiry-Moghaddam, C. Bourque, P. Agre, and O. R. Ottersen, “Specialized membrane domains for water transport in glial cells: high- resolution immunogold cytochemistry of aquaporin-4 in rat brain,” Journal of Neuroscience, vol. 17, no. 1, pp. 171–180, 1997. View at Google Scholar · View at Scopus
  6. J. Retelade and A. S. Verkman, “Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies,” The International Journal of Biochemistry & Cell Biology, vol. 44, no. 9, pp. 1519–1530, 2012. View at Google Scholar
  7. D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, and B. G. Weinshenker, “Revised diagnostic criteria for neuromyelitis optica,” Neurology, vol. 66, no. 10, pp. 1485–1489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Wingerchuk, V. A. Lennon, C. F. Lucchinetti, S. J. Pittock, and B. G. Weinshenker, “The spectrum of neuromyelitis optica,” The Lancet Neurology, vol. 6, no. 9, pp. 805–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Kim, S. H. Kim, S. H. Lee, X. F. Li, and H. J. Kim, “Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder,” Multiple Sclerosis, vol. 17, no. 9, pp. 1107–1112, 2011. View at Google Scholar
  10. S. H. Kim, W. Kim, M. C. Kook, E. K. Hong, and H. J. Kim, “Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality,” Multiple Sclerosis, vol. 18, no. 9, pp. 1340–1343, 2012. View at Google Scholar
  11. M. Apiwattanakul, B. F. Popescu, M. Matiello et al., “Intractable vomiting as the initial presentation of neuromyelitis optica,” Annals of Neurology, vol. 68, no. 5, pp. 757–761, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Wingerchuk, W. F. Hogancamp, P. C. O'Brien, and B. G. Weinshenker, “The clinical course of neuromyelitis optica (Devic's syndrome),” Neurology, vol. 53, no. 5, pp. 1107–1114, 1999. View at Google Scholar · View at Scopus
  13. J. I. O'Riordan, H. L. Gallagher, A. J. Thompson et al., “Clinical, CSF, and MRI findings in Devic's neuromyelitis optica,” Journal of Neurology Neurosurgery & Psychiatry, vol. 60, no. 4, pp. 382–387, 1996. View at Google Scholar · View at Scopus
  14. P. Cabre, O. Heinzlef, H. Merle et al., “MS and neuromyelitis optica in Martinique (French West Indies),” Neurology, vol. 56, no. 4, pp. 507–514, 2001. View at Google Scholar · View at Scopus
  15. S. M. Mirsattari, J. B. Johnston, R. McKenna et al., “Aboriginals with multiple sclerosis HLA types and predominance of neuromyelitis optica,” Neurology, vol. 56, no. 3, pp. 317–323, 2001. View at Google Scholar · View at Scopus
  16. G. Modi, A. Mochan, M. Modi, and D. Saffer, “Demyelinating disorder of the central nervous system occurring in black South Africans,” Journal of Neurology Neurosurgery & Psychiatry, vol. 70, no. 4, pp. 500–505, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. M. Papais-Alvarenga, C. M. Miranda-Santos, M. Puccioni-Sohler et al., “Optic neuromyelitis syndrome in Brazilian patients,” Journal of Neurology Neurosurgery & Psychiatry, vol. 73, no. 4, pp. 429–435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. de Seze, T. Stojkovic, D. Ferriby et al., “Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile,” Journal of the Neurological Sciences, vol. 197, no. 1-2, pp. 57–61, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Misu, K. Fujihara, I. Nakashima et al., “Pure optic-spinal form of multiple sclerosis in Japan,” Brain, vol. 125, no. 11, pp. 2460–2468, 2002. View at Google Scholar · View at Scopus
  20. H. T. Chon, P. C. Li, B. Ong et al., “Severe spinal cord involvement is a universal feature of Asians with multiple sclerosis: a joint Asian study,” Neurology Journal of South East Asia, vol. 7, pp. 35–40, 2002. View at Google Scholar
  21. A. Ghezzi, R. Bergamaschi, V. Martinelli et al., “Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica,” Journal of Neurology, vol. 251, no. 1, pp. 47–52, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. J. Pittock, V. A. Lennon, K. Krecke, D. M. Wingerchuk, C. F. Lucchinetti, and B. G. Weinshenker, “Brain abnormalities in neuromyelitis optica,” Archives of Neurology, vol. 63, no. 3, pp. 390–396, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Cabrera-Gómez, L. Quevedo-Sotolongo, A. González-Quevedo et al., “Brain magnetic resonance imaging findings in relapsing neuromyelitis optica,” Multiple Sclerosis, vol. 13, no. 2, pp. 186–192, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Li, P. Xie, F. Lv et al., “Brain magnetic resonance imaging abnormalities in neuromyelitis optica,” Acta Neurologica Scandinavica, vol. 118, no. 4, pp. 218–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. B. Bichuetti, R. L. Rivero, D. M. Oliveira et al., “Neuromyelitis optica: brain abnormalities in a Brazilian cohort,” Arquivos de Neuro-Psiquiatria, vol. 66, no. 1, pp. 1–4, 2008. View at Google Scholar · View at Scopus
  26. S. Ito, M. Mori, T. Makino, S. Hayakawa, and S. Kuwabara, “‘Cloud-like enhancement’ is a magnetic resonance imaging abnormality specific to neuromyelitis optica,” Annals of Neurology, vol. 66, no. 3, pp. 425–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. J. E. Kim, S. M. Kim, S. W. Ahn et al., “Brain abnormalities in neuromyelitis optica,” Journal of the Neurological Sciences, vol. 302, no. 1-2, pp. 43–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Kim, M. S. Park, S. H. Lee et al., “Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity,” Multiple Sclerosis, vol. 16, no. 10, pp. 1229–1236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Nagaishi, M. Takagi, A. Umemura et al., “Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 12, pp. 1360–1364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. K. H. Chan, C. T. Tse, C. P. Chung et al., “Brain involvement in neuromyelitis optica spectrum disorders,” Archives of Neurology, vol. 68, no. 11, pp. 1432–1439, 2011. View at Google Scholar
  31. A. McKeon, V. A. Lennon, T. Lotze et al., “CNS aquaporin-4 autoimmunity in children,” Neurology, vol. 71, no. 2, pp. 93–100, 2008. View at Google Scholar
  32. J. A. Cabrera-Gómez, A. Saiz-Hinarejos, F. Graus et al., “Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders,” Multiple Sclerosis, vol. 14, no. 2, pp. 248–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Wang, Y. Liu, Y. Duan, and K. Li, “Brain MRI abnormalities in neuromyelitis optica,” European Journal of Radiology, vol. 80, no. 2, pp. 445–449, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Nakashima, K. Fujihara, I. Miyazawa et al., “Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 9, pp. 1073–1075, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Y. Poppe, Y. Lapierre, D. Melançon et al., “Neuromyelitis optica with hypothalamic involvement,” Multiple Sclerosis, vol. 11, no. 5, pp. 617–621, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Viegas, A. Weir, M. Esiri et al., “Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 80, no. 6, pp. 679–682, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Qiu, S. Raven, J. S. Wu et al., “Hypothalamic lesions in multiple sclerosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 7, pp. 819–822, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Nakajima, Y. Fujiki, T. Ito, H. Kitaoka, and T. Takahashi, “Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inapproapriate antidiuretic hormone secretion as an initial manifestation,” Case Reports in Neurology, vol. 3, no. 3, pp. 263–267, 2011. View at Google Scholar
  39. T. Baba, I. Nakashima, T. Kanbayashi et al., “Narcolepsy as an initial manifestation of neuromyelitis optica with antiaquaporin-4 antibody,” Journal of Neurology, vol. 256, no. 2, pp. 287–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Kanbayashi, T. Shimohata, I. Nakashima et al., “Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications,” Archives of Neurology, vol. 66, no. 12, pp. 1563–1566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Suzuki, T. Nakamura, K. Hashimoto et al., “Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patients positive for the anti-aquaporin 4 antibody,” Archives of Neurology. In press.
  42. K. Shinoda, T. Matsushita, K. Furuta et al., “Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody,” Multiple Sclerosis, vol. 17, no. 7, pp. 885–887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Hage, H. Merle, S. Jeannin, and P. Cabre, “Ocular oscillations in the neuromyelitis optica spectrum,” Journal of Neuro-Ophthalmology, vol. 31, no. 3, pp. 255–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Misu, K. Fujihara, I. Nakashima, S. Sato, and Y. Itoyama, “Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica,” Neurology, vol. 65, no. 9, pp. 1479–1482, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. B. F. G. Popescu, V. A. Lennon, J. E. Parisi et al., “Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications,” Neurology, vol. 76, no. 14, pp. 1229–1237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Takahashi, I. Miyazawa, T. Misu et al., “Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 9, pp. 1075–1078, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. E. L. Fung, L. L. Tsung, and R. C. Dale, “Aquaporin-4 autoantibody: a neurogenic cause of anorexia and weight loss,” Developmental Medicine & Child Neurology, vol. 54, no. 1, pp. 45–47, 2012. View at Google Scholar
  48. M. Nakamura, T. Misu, K. Fujihara et al., “Occurrence of acute large and edematous callosal lesions in neuromyelitis optica,” Multiple Sclerosis, vol. 15, no. 6, pp. 695–700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Makino, S. Ito, M. Mori, T. Yonezu, Y. Ogawa, and S. Kuwabara, “Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica,” Multiple Sclerosis. In press.
  50. S. Saiki, Y. Ueno, T. Moritani et al., “Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica,” Journal of the Neurological Sciences, vol. 284, no. 1-2, pp. 217–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Takahashi, K. Fujihara, I. Nakashima et al., “Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre,” Brain, vol. 130, no. 5, pp. 1235–1243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. M. Kim, J. S. Kim, Y. E. Heo, H. R. Yang, and K. S. Park, “Cortical oscillopsia without nystagmus, and isolated symptom of neuromyelitis optica spectrum disorder with anti-aquaporin 4 antibody,” Multiple Sclerosis, vol. 18, no. 2, pp. 244–247, 2012. View at Google Scholar
  53. D. H. Miller, B. G. Weinshenker, M. Filippi et al., “Differential diagnosis of suspected multiple sclerosis: a consensus approach,” Multiple Sclerosis, vol. 14, no. 9, pp. 1157–1174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. J. J. Downer, M. I. Leite, R. Carter, J. Palace, W. Küker, and G. Quaghebeur, “Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?” Neuroradiology, vol. 54, no. 4, pp. 279–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Sinnecker, J. J. Dörr, C. F. Pfueller et al., “Distinct lesion morphology at T-7 MRI differentiates neuromyelitis optica from multiple sclerosis,” Neurology, vol. 79, no. 7, pp. 708–714, 2012. View at Google Scholar
  56. M. Calabrese, M. S. Oh, A. Favaretto et al., “No MRI evidence of cortical lesions in neuromyelitis optica,” Neurology, vol. 79, no. 16, pp. 1671–1676, 2012. View at Google Scholar
  57. R. Eichel, Z. Meiner, O. Abramsky, and M. Gotkine, “Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates,” Archives of Neurology, vol. 65, no. 2, pp. 267–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. S. M. Magaña, M. Matiello, S. J. Pittock et al., “Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders,” Neurology, vol. 72, no. 8, pp. 712–717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. V. V. Brinar and C. M. Poser, “Disseminated encephalomyelitis in adults,” Clinical Neurology and Neurosurgery, vol. 110, no. 9, pp. 913–918, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. W. Young and J. N. Fink, “Multiphasic cerebral demyelination,” The New Zealand Medical Journal, vol. 122, no. 1289, pp. 77–80, 2009. View at Google Scholar · View at Scopus
  61. A. Suppiej, R. Manara, L. De Palma, D. De Grandis, V. Citton, and P. A. Battistella, “Multiphasic acute disseminated encephalomyelitis or pediatric multiple sclerosis: report of an atypical case,” Journal of Child Neurology, vol. 24, no. 2, pp. 241–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Jarius, K. Ruprecht, B. Wildemann et al., “Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients,” Journal of Neuroinflammation, vol. 9, article 14, 2012. View at Google Scholar
  63. J. H. Min, H. J. Kim, B. J. Kim et al., “Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica,” Multiple Sclerosis, vol. 15, no. 9, pp. 1069–1076, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Estiasari, T. Matsushita, K. Masaki et al., “Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjögren’s syndrome patients with central nervous system manifestations,” Multiple Sclerosis, vol. 18, no. 6, pp. 807–816, 2012. View at Google Scholar
  65. F. C. Rueda Lopes, T. Doring, C. Martins et al., “The role or demyelination in neuromyelitis optica damage, diffusion-tensor MR imaging study,” Radiology, vol. 263, no. 1, pp. 235–242, 2012. View at Google Scholar
  66. A. Grigis, V. Noblet, F. Heitz et al., “Longitudinal change detection in diffusion MRI using multivariate statistical testing on tensors,” Neuroimage, vol. 60, no. 4, pp. 2206–2221, 2012. View at Google Scholar
  67. J. de Seze, F. Blanc, S. Kremer et al., “Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 81, no. 4, pp. 409–411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Aboul-Enein, M. Krššák, R. Höftberger, D. Prayer, and W. Kristoferitsch, “Diffuse white matter damage is absent in neuromyelitis optica,” American Journal of Neuroradiology, vol. 31, no. 1, pp. 76–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Duan, Y. Liu, P. Liang et al., “Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study,” European Journal of Radiology, vol. 81, no. 2, pp. e110–e114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Blanc, V. Noblet, B. June et al., “White matter atrophy anc cognitive dysfunctions in neuromyelitis optica,” PLoS One, vol. 7, no. 4, Article ID e33878, 2012. View at Google Scholar
  71. A. Pichiecchio, E. Tavazzi, G. Poloni et al., “Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach,” Multiple Sclerosis, vol. 18, no. 6, pp. 817–824, 2012. View at Google Scholar